Pharvaris Appoints Stefan Abele, Ph.D., as Chief Technical O

ZUG, Switzerland, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 rece...

Related Keywords

Switzerland , Zurich , Züsz , Berndt Modig , Stefan Abele , Manufacturing At Idorsia Pharmaceuticals , University Of Konstanz , Actelion Pharmaceuticals , Chemical Development , Chief Technical Operations , Active Pharmaceutical Ingredients , Chief Executive Officer , Senior Vice President , Commercial Manufacturing , Idorsia Pharmaceuticals , Synthetic Organic Chemistry ,